GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bactiguard Holding AB (LTS:0QV2) » Definitions » Risk Assessment

Bactiguard Holding AB (LTS:0QV2) Risk Assessment


View and export this data going back to 2014. Start your Free Trial

What is Bactiguard Holding AB Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Bactiguard Holding AB is: No Data: Cannot be evaluated.


Competitive Comparison of Bactiguard Holding AB's Risk Assessment

For the Medical Devices subindustry, Bactiguard Holding AB's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bactiguard Holding AB's Risk Assessment Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Bactiguard Holding AB's Risk Assessment falls into.



Bactiguard Holding AB  (LTS:0QV2) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.


Bactiguard Holding AB Risk Assessment Related Terms

Thank you for viewing the detailed overview of Bactiguard Holding AB's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.


Bactiguard Holding AB (LTS:0QV2) Business Description

Traded in Other Exchanges
Address
Alfred Nobels Alle 150, Box 15, Tullinge, SWE, SE 146 21
Bactiguard Holding AB is a Sweden-based medical device company. It is engaged in the development of infection prevention solutions, which reduce the risk of infections and the use of antibiotics. Its technology is based on the Bactiguard Infection Protection (BIP), a thin coating permanently bound to the surface of medical devices. Its portfolio contains urinary catheters, endotracheal tubes, central venous catheters, Hydrocyn for disinfection and wound care, as well as sutures and other wound care products. Its geographical segments are United States, Sweden, Malaysia, China, Thailand, Bangladesh, New Zeeland, and Other countries.

Bactiguard Holding AB (LTS:0QV2) Headlines

No Headlines